NCT05721326Completed
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition Across Diverse Patient Populations in Gynecology Practices at Penn Medicine
Source: ClinicalTrials.gov · Last updated 17 Jun 2026
Brief summary (registry, in English)
The goal of this sequential study design is to increase genetic testing in those meeting national clinical guidelines. The main question it aims to answer is: which intervention is most effective in uptake of genetic testing for the target population? Participants will receive genetic testing and counseling that may initiate life-saving screenings.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1283 (actual)
- First submitted
- 30 Jan 2023
- Start date
- 1 May 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Ovarian cancer
- NCT number
- NCT05721326
What you commit to
- Study type: Interventional
- Participants enrolled: 1283
- From 1 May 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Patients who have previously received genetic counseling and/or testing
Who the study is looking for
- Patients with serous ovarian cancer diagnosed more than two years prior to study contact
- Patients with breast cancer diagnosed at \<50 years of age more than two years prior to study contact
- Patients with triple negative breast cancer diagnosed more than two years prior to study contact
- Unaffected individuals reporting a family history of ovarian cancer
- Unaffected individuals reporting a family history of male breast cancer
- Unaffected individuals reporting a family history of breast cancer \<50 years
Age in the registry: 25 years to 100 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.